Publications by authors named "Margarita Andreeva"
Event rates and incidence of post-COVID-19 condition in hospitalised SARS-CoV-2 positive children and young people and controls across different pandemic waves: exposure-stratified prospective cohort study in Moscow (StopCOVID).
Ekaterina Pazukhina Mikhail Rumyantsev Dina Baimukhambetova Elena Bondarenko Nadezhda Markina Margarita Andreeva
BMC Med
February 2024
Article Synopsis
- - The study aimed to explore long-term health outcomes in children and young people post-COVID-19, particularly focusing on post-COVID-19 condition (PCC) and incomplete recovery, comparing these outcomes with those from other non-SARS-CoV-2 infections.
- - Conducted in Moscow, researchers followed two cohorts of pediatric patients with confirmed COVID-19 from two different time periods (Wuhan and Omicron variants) and compared them to a reference group of those with other infections but negative for SARS-CoV-2.
- - Findings revealed that the incidence of PCC was significantly higher in the Wuhan variant group compared to the reference group, while the Omicron variant showed no significant difference in PCC outcomes when compared to the
Article Synopsis
- - The European Academy of Allergy and Clinical Immunology (EAACI) is revising their guidelines for diagnosing IgE-mediated food allergies, aiming to consolidate findings from 149 studies involving 24,489 patients published between 2012 and 2021.
- - Systematic reviews and meta-analyses revealed that skin prick tests (SPT) for fresh cow's milk and raw egg showed high sensitivity (90% and 94%), while specific IgE tests for individual food components demonstrated high specificity for various allergens like peanuts and eggs.
- - The basophil activation test (BAT) was found to be highly specific for diagnosing peanut (90%) and sesame (93%) allergies, indicating that while SPT and specific Ig
Article Synopsis
- - The study investigated the prevalence of post-COVID-19 condition (PCC) in adults and children who were hospitalized after contracting COVID-19, using a defined WHO standard and conducting follow-ups at 6 and 12 months post-discharge.
- - Findings showed a PCC prevalence of 50% in adults and 20% in children at 6 months, decreasing to 34% and 11%, respectively, at 12 months; factors such as female sex and hypertension in adults, and neurological comorbidities in children were linked to higher PCC risk.
- - The results highlight the importance of monitoring for ongoing health issues following COVID-19, particularly in higher-risk groups, as a significant number of individuals experienced
Article Synopsis
- The study investigated long-term symptoms in hospitalized COVID-19 patients, finding that 47.1% reported ongoing issues like fatigue, shortness of breath, and forgetfulness after discharge.
- Data was gathered from 2,649 patients in Moscow, focusing on their experiences 218 days post-discharge, showing that while many cases were mild, some required significant medical interventions.
- Female patients had a higher likelihood of persistent symptoms, particularly skin issues, while asthma was linked to neurological and mood-related changes.
Background: The long-term sequelae of coronavirus disease 2019 (COVID-19) in children remain poorly characterised. This study aimed to assess long-term outcomes in children previously hospitalised with COVID-19 and associated risk factors.
Methods: This is a prospective cohort study of children (≤18 years old) admitted to hospital with confirmed COVID-19.